Untargeted metabolomics reveals L-Lysine depletion as a host-directed therapeutic target in Toxoplasma gondii infection.
This study identifies L-lysine depletion as a metabolic feature of T. gondii infection and demonstrates that its supplementation confers measurable host-protective benefits, and supports the concept of L-lysine supplementation as a host-directed adjunctive intervention to mitigate pathology during toxoplasmosis.